Alessandra  Faria

Dr. Alessandra Faria

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AFAlessandra Faria
Alessandra Faria
AAAdamu Ishaku Akyala
Adamu Ishaku Akyala
KPKaushal Parikh
Kaushal Parikh
LBLois W. Brüggemann
Lois W. Brüggemann
CSC. Arnold Spek
C. Arnold Spek
Maikel PeppelenboschMaikel Peppelenbosch
Maikel Peppelenbosch
Hedgehog proteins are pivotal morphogens acting through a canonical pathway involving first activation of ligand binding to Patched followed by alleviation of Smoothened receptor inhibition, leading to activation of Gli transcription factors. Noncanonical Hedgehog signaling remains poorly characterized but is thought to be mainly dependent on Smoothened. However, Smoothened inhibitors have yielded only partial success in combating Hedgehog signal transduction-dependent cancer, suggesting that noncanonical Smoothened-independent pathways also are clinically relevant. Moreover, several Smoothened-dependent effects (e.g. neurite projection) do not require transcriptional activation, further suggesting biological importance of noncanonical Smoothened-dependent pathways. We comprehensively characterized the cellular kinome in Hedgehog-challenged murine WT and Smoothened(-/-) fibroblasts as well as Smoothened agonist-stimulated cells. A peptide assay-based kinome analysis (in which cell lysates are used to phosphorylate specific kinase substrates), along with endocytosis, Lucifer Yellow-based, and immunoblotting assays, identified an elaborate signaling network of both Smoothened-dependent and -independent pathways that mediates actin reorganization through Src-like kinases, activates various proinflammatory signaling cascades, and concomitantly stimulates Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling. The contribution of noncanonical Smoothened-independent signaling to the overall effects of Hedgehog on cellular physiology appears to be much larger than previously envisioned and may explain the transcriptionally independent effects of Hedgehog signaling on cytoskeleton. The observation that Patched-dependent, Smoothened-independent, noncanonical Hedgehog signaling increases Wnt/Notch signaling provides a possible explanation for the failure of Smoothened antagonists in combating Hedgehog-dependent but Smoothened inhibitor-resistant cancer. Our findings suggest that inhibiting Hedgehog-Patched interaction could result in more effective therapies as compared with conventional Smoothened-directed therapies.

18 October 2022 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
HKHeikki Kyykallio
Heikki Kyykallio
AFAlessandra Faria
Alessandra Faria
RHRosabella Hartman
Rosabella Hartman
JCJanne Capra
Janne Capra
KRKirsi Rilla
Kirsi Rilla
PSPia Siljander
Pia Siljander
Recent advances in cell biology research regarding extracellular vesicles have highlighted an increasing demand to obtain 3D cell culture‐derived EVs, because they are considered to more accurately represent EVs obtained in vivo. However, there is still a grave need for efficient and tunable methodologies to isolate EVs from 3D cell cultures. Using nanofibrillar cellulose (NFC) scaffold as a 3D cell culture matrix, we developed a pipeline of two different approaches for EV isolation from cancer spheroids. A batch method was created for delivering high EV yield at the end of the culture period, and a harvesting method was created to enable time‐dependent collection of EVs to combine EV profiling with spheroid development. Both these methods were easy to set up, quick to perform, and they provided a high EV yield. When compared to scaffold‐free 3D spheroid cultures on ultra‐low affinity plates, the NFC method resulted in similar EV production/cell, but the NFC method was scalable and easier to perform resulting in high EV yields. In summary, we introduce here an NFC‐based, innovative pipeline for acquiring EVs from 3D cancer spheroids, which can be tailored to support the needs of variable EV research objectives.

6 June 2022 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
POPatricia F. de Souza Oliveira
Patricia F. de Souza Oliveira
AFAlessandra Faria
Alessandra Faria
SCStefano P. Clerici
Stefano P. Clerici
EAErica M. Akagi
Erica M. Akagi
Hernandes CarvalhoHernandes Carvalho
Hernandes Carvalho
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder

Verified
Journal Article
Open access
PDF file
AFAlessandra Faria
Alessandra Faria
SASheila Andrade
Sheila Andrade
ARAgnes N. Reijm
Agnes N. Reijm
MSManon C.W. Spaander
Manon C.W. Spaander
MMMoniek P.M. Maat
Moniek P.M. Maat
GFGwenny Fuhler
Gwenny Fuhler
Venous thromboembolism (VTE) is one of the most common causes of cancer related mortality. It has been speculated that hypercoagulation in cancer patients is triggered by direct or indirect contact of platelets with tumor cells, however the underlying molecular mechanisms involved are currently unknown. Unraveling these mechanisms may provide potential avenues for preventing platelet-tumor cell aggregation. Here, we investigated the role of protein tyrosine phosphatases in the functionality of platelets in both healthy individuals and patients with gastrointestinal cancer, and determined their use as a target to inhibit platelet hyperactivity. This is the first study to demonstrate that platelet agonists selectively activate low molecular weight protein tyrosine phosphatase (LMWPTP) and PTP1B, resulting in activation of Src, a tyrosine kinase known to contribute to several platelet functions. Furthermore, we demonstrate that these phosphatases are a target for 3-bromopyruvate (3-BP), a lactic acid analog currently investigated for its use in the treatment of various metabolic tumors. Our data indicate that 3-BP reduces Src activity, platelet aggregation, expression of platelet activation makers and platelet-tumor cell interaction. Thus, in addition to its anti-carcinogenic effects, 3-BP may also be effective in preventing platelet-tumor cell aggregationin cancer patients and therefore may reduce cancer mortality by limiting VTE in patients.

7 April 2017 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
AFAlessandra Faria
Alessandra Faria
TTThaís F. Tornatore
Thaís F. Tornatore
RMRenato Milani
Renato Milani
KQKarla C.S. Queiroz
Karla C.S. Queiroz
ISIgor H. Sampaio
Igor H. Sampaio
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder

8 April 2020
Verified
Book Chapter
Open access
PDF file
CFCarmen V. Ferreira-Halder
Carmen V. Ferreira-Halder
SCStefano Piatto Clerici
Stefano Piatto Clerici
AFAlessandra Faria
Alessandra Faria
POPatrícia Fernandes de Souza Oliveira
Patrícia Fernandes de Souza Oliveira
HCHelon Guimarães Cordeiro
Helon Guimarães Cordeiro
EAErica Akagi
Erica Akagi
Reversible phosphorylation of proteins, executed by kinases and phosphatases, is the major posttranslational protein modification in eukaryotic cells, causing them to become activated or deactivated. This intracellular event represents a critical regulatory mechanism of several signaling pathways and can be related to a broad number of diseases, including cancer. Few decades ago, protein tyrosine phosphatases (PTPs) were considered as tumor suppressors. However, nowadays, accumulating evidence demonstrates that a misregulation of PTP activities plays a crucial and decisive role in cancer progression and metastasis. In this chapter, we will focus on the molecular aspects that support the crucial role of PTPs in cancer and in turn make them promising for prediction, monitoring, and rational appropriate therapy selection of individual patients.